Bank of New York Mellon
OSIR

Bank of New York Mellon’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Bank of New York Mellon’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-10,227
Closed -$138K – 4340
2018
Q4 		$138K Hold
10,227
– – ﹤0.01% 3917
2018
Q3 		$114K Buy
+10,227
New +$102K ﹤0.01% 4020
2017
Q1 		– Sell
-85,328
Closed -$419K – 4404
2016
Q4 		$419K Buy
85,328
+7,730
+10% +$39.6K ﹤0.01% 3662
2016
Q3 		$385K Sell
77,598
-6,460
-8% -$33.1K ﹤0.01% 3655
2016
Q2 		$428K Sell
84,058
-18,024
-18% -$97.1K ﹤0.01% 3604
2016
Q1 		$582K Buy
102,082
+14,385
+16% +$100K ﹤0.01% 3365
2015
Q4 		$910K Buy
87,697
+5,210
+6% +$70.7K ﹤0.01% 3232
2015
Q3 		$1.52M Sell
82,487
-18,311
-18% -$353K ﹤0.01% 2908
2015
Q2 		$1.96M Buy
100,798
+5,794
+6% +$103K ﹤0.01% 2923
2015
Q1 		$1.67M Sell
95,004
-2,138
-2% -$35.9K ﹤0.01% 2989
2014
Q4 		$1.55M Buy
97,142
+4,496
+5% +$60.2K ﹤0.01% 3024
2014
Q3 		$1.17M Buy
92,646
+10,474
+13% +$149K ﹤0.01% 3197
2014
Q2 		$1.28M Buy
82,172
+115
+0.1% +$1.69K ﹤0.01% 3172
2014
Q1 		$1.08M Buy
82,057
+348
+0.4% +$5.45K ﹤0.01% 3234
2013
Q4 		$1.31M Sell
81,709
-2,788
-3% -$44.4K ﹤0.01% 3138
2013
Q3 		$1.41M Sell
84,497
-13,202
-14% -$195K ﹤0.01% 3058
2013
Q2 		$983K Buy
+97,699
New +$1.03M ﹤0.01% 3205

Other funds holding OSIR

AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CCM
Cloverdale Capital Management Dallas, Texas $135M AUM 13.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Bank of New York Mellon's OSIR Position: Q1 2019 in Review

Bank of New York Mellon sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q1 2019, closing a stake of 10,227 shares — an estimated $138K sold.

Bank of New York Mellon first reported a position in OSIR in Q2 2013 and held it in 17 quarters. The position peaked at $1.96M in Q2 2015. 57 funds tracked by Wall St. Rank hold OSIR as of Q1 2019.

  • Bank of New York Mellon reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • Bank of New York Mellon sold 10,227 Osiris Therapeutics, Inc. Common Stock shares in Q1 2019, an estimated $138K.
  • Bank of New York Mellon first reported a position in Osiris Therapeutics, Inc. Common Stock in Q2 2013 and held it in 17 quarters.
  • Bank of New York Mellon's Osiris Therapeutics, Inc. Common Stock position peaked at $1.96M in Q2 2015.
  • 57 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q1 2019.

Based on Bank of New York Mellon's 13F filing for Q1 2019, filed 14 May 2019.